Clinical Trial Update: Conversion of CellCept to Myfortic: A Prospective Study in Liver Transplant Recipients [NA]

View source ↗

Summary

This prospective study in liver transplant recipients examines converting immunosuppression from CellCept (mycophenolate mofetil) to Myfortic (mycophenolic acid…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Transplantation

Drugs mentioned

• CELLCEPT (mycophenolate mofetil hydrochloride)
• MYFORTIC (MYCOPHENOLIC ACID)

Snippet

Sponsor: University of Pittsburgh | Conditions: Immunosuppression | NA | Status: COMPLETED | Results posted: 2016-11-07